vaccines | GenomeWeb

vaccines

Make Your Own Vaccine

There are a number of efforts underway to develop DNA vaccines for diseases like Zika, according to the Wall Street Journal.

The two partners hope to start a Phase I combination trial pairing Genentech's anti-PDL1 cancer immunotherapy Tecentriq with vaccines developed using BioNTech's IVAC Mutanome. 

US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.

Elaine Mardis of Washington University in St. Louis described genome-guided efforts to identify neoantigen targets for cancer vaccines in melanoma and other cancer types.

The program will use transcriptomics, proteomics, lipidomics, and metabolomics to explore immune response.

NEW YORK (GenomeWeb) – The National Institute of Allergy and Infectious Diseases plans to fund research focused on better understanding the biology and immunology of natural viral infections and HIV vaccine vectors, including studies that will use a wide range of omics approaches.

NEW YORK (GenomeWeb News) – Agilent Technologies, a University of Rouen laboratory, and the Bioprocessing Technology Institute in Singapore have signed a memorandum of understanding for the development of tools to analyze biologics and vaccines.

The new venture also will work with Novartis on accelerating the production of influenza seed strains required for vaccine manufacturing.

The $600,000 award also strengthens Inviragen's ties to UW-Madison. The company's CSO maintains an academic appointment and a research lab within the School of Veterinary Medicine, which has collaborated with Inviragen on other projects.

BioRegion Real Estate

Premium

Massachusetts Biotechnology Council-BioReady Communities Campaign, Alkermes Relocation, Science + Technology Park at Johns Hopkins, Ohio State University Wright Center of Innovation in Biomedical Imaging, Londonderry Clinical Translational Research and Innovation Centre, Aeras Global TB Vaccine Foundation, BioBusiness Park at Elk Run, Chrysler-University of Delaware, ICON- Qualia Clinical Services

Pages

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.